TickerFactsScreenerDevelopers

NEKTAR THERAPEUTICS (NKTR) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $190.15M2009: $102.37M2010: $90.66M2011: $197.81M2012: $47.02M2013: -$89.90M2014: $36.33M2015: $6.43M2016: $88.12M2017: $87.83M2018: $1.72B2019: $1.41B2020: $1.08B2021: $679.51M2022: $366.64M2023: $130.99M2024: $60.74M2025: $89.83M$89.83M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$89.83M+47.9%
2024$60.74M-53.6%
2023$130.99M-64.3%
2022$366.64M-46.0%
2021$679.51M-36.9%
2020$1.08B-23.3%
2019$1.41B-18.2%
2018$1.72B+1855.6%
2017$87.83M-0.3%
2016$88.12M+1270.7%
2015$6.43M-82.3%
2014$36.33M+140.4%
2013-$89.90M-291.2%
2012$47.02M-76.2%
2011$197.81M+118.2%
2010$90.66M-11.4%
2009$102.37M-46.2%
2008$190.15M—